Oventus Medical Limited, a medical device company, develops and commercializes oral appliances for the treatment of obstructive sleep apnoea (OSA) and snoring in Australia, Canada, and the United States. The company offers O2Vent Optima, a 3D-printed nylon oral appliance for OSA patients; and ExVent, a valve accessory that fits into the open airway of the O2Vent Optima device. The company was incorporated in 2015 and is headquartered in Indooroopilly, Australia.
| Market Capitalization | $9.1856 million |
| P/E Ratio | |
| P/E Growth Ratio | |
| Book Value | 0.033 |
| Dividend Per Share | 0 |
| Earnings Per Share | -0.051 |
| EBITDA | -7,952.483 |
| Profit Margin | 0 |
| Operating Margin TTM | -9.8954 |
| Return on Assets TTM | -0.6482 |
| Return on Equity TTM | -1.2704 |
| Revenue TTM | 1,093.535 |
All numbers are in thousands
| Date | Total Revenue | Cost of Revenue | Gross Profit | Total Operating Expenses |
|---|---|---|---|---|
| 2014-06-30 | 0 | 0 | 0 | 9.452 |
| 2015-06-30 | 56.91 | 63.04 | -6.13 | 237.493 |
| 2016-06-30 | 553.04 | 512.01 | 41.03 | 2,894.113 |
| 2017-06-30 | 447.994 | 582.43 | 447.994 | 7,097.982 |
| 2018-06-30 | 271.322 | 177.7 | 271.322 | 6,424.042 |
| 2019-06-30 | 331.837 | 158.24 | 331.837 | 8,486.805 |
| 2020-06-30 | 419.298 | 231.736 | 187.562 | 10,425.216 |
| 2021-06-30 | 1,089.535 | 687.912 | 401.623 | 10,359.011 |
All numbers are in thousands
| Date | Cash | Total Assets | Total Liabilities | Short Term Debt | Long Term Debt | Common Stock |
|---|---|---|---|---|---|---|
| 2015-06-30 | 42.876 | 1,060.326 | 908.288 | 546.881 | 342.857 | |
| 2016-06-30 | 13,755.322 | 15,675.778 | 989.751 | 92.875 | 15,611.703 | |
| 2017-06-30 | 8,648.099 | 14,119.831 | 1,230.799 | 21,729.732 | ||
| 2018-06-30 | 9,894.959 | 15,812.513 | 682.243 | 29,640.394 | ||
| 2019-06-30 | 2,998.563 | 8,959.475 | 1,602.87 | 29,640.394 | ||
| 2020-06-30 | 8,455.393 | 14,327.104 | 2,111.079 | 46.217 | 44,333.763 | |
| 2021-06-30 | 9,156.547 | 15,078.618 | 2,460.52 | 218.889 | 53,638.986 |
All numbers are in thousands
| Date | Net Income | Total Cash | Change in Cash | Begin period cash | End period cash | Dividends |
|---|---|---|---|---|---|---|
| 2014-06-30 | -9.452 | -75.928 | 42.45 | |||
| 2015-06-30 | -180.579 | -75.93 | 42.45 | |||
| 2016-06-30 | -2,341.078 | -1,503.97 | 118.24 | 161.114 | ||
| 2017-06-30 | -6,510.114 | -5,530.076 | 8,486.985 | 161.114 | 8,648.099 | 0 |
| 2018-06-30 | -5,870.547 | -4,635.049 | 1,246.86 | 8,648.099 | 9,894.959 | |
| 2019-06-30 | -7,848.255 | -4,912.14 | -6,896.396 | 9,894.959 | 2,998.563 | |
| 2020-06-30 | -10,126.364 | -7,669.006 | 5,456.83 | 2,998.563 | 8,455.393 | |
| 2021-06-30 | -9,831.562 | -6,923.595 | 701.154 | 8,455.393 | 9,156.547 |